Page last updated: 2024-08-23

atomoxetine hydrochloride and Depressive Disorder

atomoxetine hydrochloride has been researched along with Depressive Disorder in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19903 (23.08)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geyer, MA; Phillips, AG; Robbins, TW1
Lee, MJ; Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS1
Anderson, RH; Mattingly, GW1
Swann, AC1
Dworkin, N1
Adler, L; Hedges, DW; Marchant, BK; Reimherr, FW; Soni, P; Spencer, TJ; Strong, RE; West, SA1
Arnold, LE; Biederman, J; Duesenberg, D; Emslie, GJ; Gao, H; Kratochvil, CJ; Michelson, D; Newcorn, JH; Quintana, H; Sarkis, EH; Wagner, KD1
Carpenter, LL; Milosavljevic, N; Price, LH; Schecter, JM; Tyrka, AR1
Bebarta, VS; Gonzalez, MG; Kostic, MA1
Adler, LA; Biederman, J; Faraone, SV; Glatt, SJ; Michelson, D; Reimherr, FW; Spencer, TJ1
Annable, L; Bradwejn, J; Chouinard, G1
Annable, L; Belanger, MC; Bradwejn, J; Chouinard, G; Jones, B; Labonte, A; Mercier, P1
Chouinard, G; Steinberg, S1

Reviews

4 review(s) available for atomoxetine hydrochloride and Depressive Disorder

ArticleYear
Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders.
    Biological psychiatry, 2018, 06-01, Volume: 83, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Drug Discovery; Humans; Ketamine; Mental Disorders; Models, Animal; Nicotinic Agonists; Tobacco Use Disorder; Varenicline

2018
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
    CNS spectrums, 2016, Volume: 21, Issue:S1

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Clonidine; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Dextroamphetamine; Guanfacine; Humans; Methylphenidate

2016
Pharmacologic mood destabilization: case vignettes.
    CNS spectrums, 2009, Volume: 14, Issue:11 Suppl 1

    Topics: Adult; Affect; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Humans; Lamotrigine; Male; Middle Aged; Phenylpropanolamine; Propylamines; Rhinitis, Allergic, Seasonal; Triazines

2009
Managing adverse reactions to psychotropic medications.
    Pediatric annals, 2005, Volume: 34, Issue:12

    Topics: Adolescent; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Death, Sudden; Depressive Disorder; Humans; Poisoning; Propylamines; Psychotropic Drugs; Suicide, Attempted; Valproic Acid

2005

Trials

4 trial(s) available for atomoxetine hydrochloride and Depressive Disorder

ArticleYear
Emotional dysregulation in adult ADHD and response to atomoxetine.
    Biological psychiatry, 2005, Jul-15, Volume: 58, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adult; Affective Symptoms; Analysis of Variance; Anxiety Disorders; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Norepinephrine; Propylamines

2005
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:9

    Topics: Adolescent; Anxiety; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Propylamines; Selective Serotonin Reuptake Inhibitors

2005
Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Adult; Ambulatory Care; Antidepressive Agents; Atomoxetine Hydrochloride; Blood Pressure; Body Mass Index; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Personality Inventory; Propylamines; Psychiatric Status Rating Scales; Sexual Dysfunctions, Psychological; Treatment Outcome

2005
Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Health Status; Humans; Male; Mental Disorders; Neuropsychological Tests; Norepinephrine Plasma Membrane Transport Proteins; Placebos; Propylamines; Psychiatric Status Rating Scales; Risk Factors; Stress Disorders, Post-Traumatic; Treatment Outcome

2006

Other Studies

5 other study(ies) available for atomoxetine hydrochloride and Depressive Disorder

ArticleYear
Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan.
    Journal of affective disorders, 2016, Jan-01, Volume: 189

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Depressive Disorder; Female; Humans; Male; Methylphenidate; Probability; Retrospective Studies; Taiwan

2016
Increased blood pressure and atomoxetine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Norepinephrine; Propylamines

2005
An early phase II clinical trial of tomoxetine (LY139603) in the treatment of newly admitted depressed patients.
    Psychopharmacology, 1984, Volume: 83, Issue:1

    Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Middle Aged; Propylamines; Psychiatric Status Rating Scales

1984
An early Phase II clinical trial with followup of tomoxetine (LY139603) in the treatment of newly admitted depressed patients.
    Psychopharmacology bulletin, 1985, Volume: 21, Issue:1

    Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Middle Aged; Propylamines

1985
A case of mania associated with tomoxetine.
    The American journal of psychiatry, 1985, Volume: 142, Issue:12

    Topics: Atomoxetine Hydrochloride; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Propylamines

1985